Medicine and Dentistry
Pulmonary Hypertension
100%
Bronchoscopy
48%
Pulmonary Embolism
46%
Thrombotic Thrombocytopenic Purpura
38%
Proteasome Inhibitor
38%
Respiratory Failure
38%
Lung Tumor
38%
Lupus Erythematosus
38%
Endobronchial Ultrasonography
38%
Hyponatremia
38%
Multiple Myeloma
38%
Scleroderma
38%
Lung Lesion
38%
Volume CT
38%
Nocardiosis
38%
Lung
38%
Pulmonary Artery
28%
Carfilzomib
28%
Cancer
20%
Lymphocytopenia
19%
Nocardia
19%
Opportunistic Infection
19%
Stenosis
17%
Diagnostic Accuracy
16%
Right Ventricle
15%
Transbronchial Biopsy
15%
Cardiac Catheterization
15%
Prevalence
15%
Systemic Scleroderma
10%
Biopsy Technique
10%
Infection
9%
Artery Lesion
9%
Physical Disease by Body Function
9%
Mediastinitis
9%
Antibiotics
9%
Diseases
9%
Agenesis
9%
Clinical Feature
9%
Early Diagnosis
9%
Diagnostic Error
9%
Clinician
9%
Bortezomib
9%
Multiple Pulmonary Nodules
9%
Connective Tissue Disease
8%
Adenocarcinoma
7%
Gastroesophageal Junction
7%
Blood Clotting
7%
Pulseless Electrical Activity
7%
Systolic Function
7%
Arteriole
7%
Keyphrases
Shape Sensing
38%
Pulmonary Tumor Thrombotic Microangiopathy
38%
Lung Opacity
38%
Pulmonary Arterial Hypertension
38%
Hyponatremia
38%
1-year Mortality
25%
Sodium Levels
19%
Functional Class
19%
Existance
12%
Congenital Stenosis
12%
Pulmonary Vasculitis
7%
Small Pulmonary Vessels
7%
Treprostinil
6%
Chronic Hyponatremia
6%
Right Atrial Pressure
6%
Well-defined
6%
Poor Prognosis
6%
Overall Mortality
6%
6-minute Walk Distance (6MWD)
6%
Heart Failure Disease
6%
Mortality Hazard
6%
Left Heart Failure
6%
Liver Disease
6%
Unadjusted Analyses
6%
Prognostic Role
6%
Tertiary Care Hospital
6%
Sodium
6%
Hazard Ratio
6%
Large Cohort
6%
Additional Sampling
5%
Diagnostic Sampling
5%
